Rein Therapeutics, Inc. (RNTX) Reports Material Event to SEC

Rein Therapeutics, Inc. (NASDAQ:RNTX) filed a Form 8-K with the Securities and Exchange Commission on February 19, 2026, disclosing a material event.

Rein Therapeutics, Inc.'s stock currently trades at $1.12 with a market capitalization of $40.2M. The Healthcare company's stock moved following the disclosure.